Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP751911.RAywJWf117rcsb9tcJvaBR3eQlkdelh1tEDm59FsI9qQE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP751911.RAywJWf117rcsb9tcJvaBR3eQlkdelh1tEDm59FsI9qQE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP751911.RAywJWf117rcsb9tcJvaBR3eQlkdelh1tEDm59FsI9qQE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP751911.RAywJWf117rcsb9tcJvaBR3eQlkdelh1tEDm59FsI9qQE130_provenance.
- NP751911.RAywJWf117rcsb9tcJvaBR3eQlkdelh1tEDm59FsI9qQE130_assertion description "[The Mdm2 inhibitor nutlin-3 was evaluated alone and in combination with cisplatin in a panel of germ cell tumour (GCT)-derived cell lines (embryonal carcinomas, being the nonseminomatous stem-cell component) with wild-type (NT2 and 2102EP cells) and mutant (NCCIT cells) p53 status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP751911.RAywJWf117rcsb9tcJvaBR3eQlkdelh1tEDm59FsI9qQE130_provenance.
- NP751911.RAywJWf117rcsb9tcJvaBR3eQlkdelh1tEDm59FsI9qQE130_assertion evidence source_evidence_literature NP751911.RAywJWf117rcsb9tcJvaBR3eQlkdelh1tEDm59FsI9qQE130_provenance.
- NP751911.RAywJWf117rcsb9tcJvaBR3eQlkdelh1tEDm59FsI9qQE130_assertion SIO_000772 19560254 NP751911.RAywJWf117rcsb9tcJvaBR3eQlkdelh1tEDm59FsI9qQE130_provenance.
- NP751911.RAywJWf117rcsb9tcJvaBR3eQlkdelh1tEDm59FsI9qQE130_assertion wasDerivedFrom befree-20150227 NP751911.RAywJWf117rcsb9tcJvaBR3eQlkdelh1tEDm59FsI9qQE130_provenance.
- NP751911.RAywJWf117rcsb9tcJvaBR3eQlkdelh1tEDm59FsI9qQE130_assertion wasGeneratedBy ECO_0000203 NP751911.RAywJWf117rcsb9tcJvaBR3eQlkdelh1tEDm59FsI9qQE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP751911.RAywJWf117rcsb9tcJvaBR3eQlkdelh1tEDm59FsI9qQE130_provenance.